The experimental evidence explains the cellular and molecular mechanisms of estrogen-mediated protection against colorectal tumorigenesis and suggests that ESR1 future challenges and potential avenues for colorectal cancer targeted therapy. Here, ESR1 is linked to colorectal cancer.